FindTrial
Sign In

Long-term prognosis of patients with autoimmune encephalitis

Long-term follow-up and factors associated prognosis in patients with autoimmune encephalitis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056542
Enrollment
Unknown
Registered
2022-02-07
Start date
2022-02-07
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

autoimmune encephalitis

Interventions

Case series:None

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients who meet the international consensus on autoimmune encephalitis diagnosis in 2016.

Exclusion criteria

Exclusion criteria: 1. Patients who refused to participate in the study; 2. Patients with other central nervous system diseases.

Design outcomes

Primary

MeasureTime frame
CSF antibodies;Brain MRI;—

Secondary

MeasureTime frame
Neuropsychological assessment;—

Countries

China

Contacts

Public ContactLi Jinmei

West China Hospital, Sichuan University

lijinmei@wchscu.cn+86 18980605697

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026